A detailed history of Braidwell LP transactions in Alector, Inc. stock. As of the latest transaction made, Braidwell LP holds 2,158,245 shares of ALEC stock, worth $4.01 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
2,158,245
Previous 2,380,704 9.34%
Holding current value
$4.01 Million
Previous $10.8 Billion 6.95%
% of portfolio
0.29%
Previous 0.34%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.34 - $6.58 $965,472 - $1.46 Million
-222,459 Reduced 9.34%
2,158,245 $10.1 Billion
Q1 2024

May 15, 2024

SELL
$5.69 - $8.08 $5.37 Million - $7.62 Million
-943,604 Reduced 28.38%
2,380,704 $14.3 Billion
Q4 2023

Feb 14, 2024

SELL
$3.77 - $8.39 $2.83 Million - $6.29 Million
-749,812 Reduced 18.4%
3,324,308 $26.5 Billion
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $297,414 - $501,600
-57,195 Reduced 1.38%
4,074,120 $26.4 Billion
Q2 2023

Aug 14, 2023

BUY
$5.86 - $7.93 $5.42 Million - $7.34 Million
925,000 Added 28.85%
4,131,315 $24.8 Billion
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $14.5 Million - $24.4 Million
2,481,291 Added 342.24%
3,206,315 $19.8 Billion
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $4.99 Million - $6.92 Million
725,024 New
725,024 $6.69 Billion

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.